Pharma-Bio Serv, Inc. (PBSV)
USD 0.46
(-9.8%)
USD 0.46
(-9.8%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 194.03 Thousand USD | -44.0% |
| 2022 | 346.5 Thousand USD | -28.9% |
| 2021 | 487.36 Thousand USD | -63.34% |
| 2020 | 1.32 Million USD | 1881.72% |
| 2019 | 67.07 Thousand USD | 45.74% |
| 2018 | 46.02 Thousand USD | -23.03% |
| 2017 | 59.79 Thousand USD | 106.18% |
| 2016 | 29 Thousand USD | -44.18% |
| 2015 | 51.95 Thousand USD | -30.49% |
| 2014 | 74.73 Thousand USD | 44.49% |
| 2013 | 51.72 Thousand USD | -38.36% |
| 2012 | 83.91 Thousand USD | -9.03% |
| 2011 | 92.23 Thousand USD | 71.32% |
| 2010 | 53.83 Thousand USD | -13.7% |
| 2009 | 62.38 Thousand USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 153.99 Thousand USD | 0.0% |
| 2024 Q3 | 71.36 Thousand USD | 0.0% |
| 2024 Q2 | 113.04 Thousand USD | 0.0% |
| 2023 FY | 194.03 Thousand USD | -44.0% |
| 2023 Q2 | 271.73 Thousand USD | -12.22% |
| 2023 Q1 | 309.56 Thousand USD | -10.66% |
| 2023 Q3 | 233.27 Thousand USD | -14.15% |
| 2023 Q4 | 194.03 Thousand USD | -16.82% |
| 2022 Q2 | 418.2 Thousand USD | -7.74% |
| 2022 Q3 | 382.71 Thousand USD | -8.49% |
| 2022 FY | 346.5 Thousand USD | -28.9% |
| 2022 Q4 | 346.5 Thousand USD | -9.46% |
| 2022 Q1 | 453.27 Thousand USD | -6.99% |
| 2021 Q3 | 523.96 Thousand USD | -56.47% |
| 2021 FY | 487.36 Thousand USD | -63.34% |
| 2021 Q2 | 1.2 Million USD | -6.79% |
| 2021 Q4 | 487.36 Thousand USD | -6.98% |
| 2021 Q1 | 1.29 Million USD | -2.85% |
| 2020 Q4 | 1.32 Million USD | -21.25% |
| 2020 FY | 1.32 Million USD | 1881.72% |
| 2020 Q1 | 793.61 Thousand USD | 1083.11% |
| 2020 Q2 | 2.04 Million USD | 157.81% |
| 2020 Q3 | 1.68 Million USD | -17.5% |
| 2019 FY | 67.07 Thousand USD | 45.74% |
| 2019 Q1 | 42.51 Thousand USD | -7.62% |
| 2019 Q2 | 72.66 Thousand USD | 70.91% |
| 2019 Q3 | 69.89 Thousand USD | -3.82% |
| 2019 Q4 | 67.07 Thousand USD | -4.02% |
| 2018 Q4 | 46.02 Thousand USD | -7.03% |
| 2018 Q3 | 49.5 Thousand USD | -6.53% |
| 2018 Q2 | 52.96 Thousand USD | -6.09% |
| 2018 Q1 | 56.39 Thousand USD | -5.68% |
| 2018 FY | 46.02 Thousand USD | -23.03% |
| 2017 FY | 59.79 Thousand USD | 106.18% |
| 2017 Q3 | 63.16 Thousand USD | 212.6% |
| 2017 Q2 | 20.2 Thousand USD | -17.98% |
| 2017 Q1 | 24.63 Thousand USD | -15.06% |
| 2017 Q4 | 59.79 Thousand USD | -5.33% |
| 2016 Q4 | 29 Thousand USD | -14.53% |
| 2016 Q2 | 40.02 Thousand USD | -13.05% |
| 2016 Q1 | 46.03 Thousand USD | -11.39% |
| 2016 FY | 29 Thousand USD | -44.18% |
| 2016 Q3 | 33.93 Thousand USD | -15.23% |
| 2015 Q3 | 57.78 Thousand USD | -9.04% |
| 2015 FY | 51.95 Thousand USD | -30.49% |
| 2015 Q1 | 69.17 Thousand USD | -7.44% |
| 2015 Q2 | 63.52 Thousand USD | -8.17% |
| 2015 Q4 | 51.95 Thousand USD | -10.09% |
| 2014 FY | 74.73 Thousand USD | 44.49% |
| 2014 Q2 | 109.84 Thousand USD | 139.46% |
| 2014 Q3 | 100.67 Thousand USD | -8.35% |
| 2014 Q4 | 74.73 Thousand USD | -25.76% |
| 2014 Q1 | 45.87 Thousand USD | -11.31% |
| 2013 Q4 | 51.72 Thousand USD | -11.9% |
| 2013 Q3 | 58.71 Thousand USD | -10.45% |
| 2013 Q2 | 65.56 Thousand USD | -10.86% |
| 2013 Q1 | 73.55 Thousand USD | -12.34% |
| 2013 FY | 51.72 Thousand USD | -38.36% |
| 2012 Q1 | 84.03 Thousand USD | -8.9% |
| 2012 Q2 | 75.65 Thousand USD | -9.97% |
| 2012 Q3 | 67.11 Thousand USD | -11.3% |
| 2012 Q4 | 83.91 Thousand USD | 25.03% |
| 2012 FY | 83.91 Thousand USD | -9.03% |
| 2011 Q1 | 49.05 Thousand USD | -8.88% |
| 2011 FY | 92.23 Thousand USD | 71.32% |
| 2011 Q4 | 92.23 Thousand USD | -8.01% |
| 2011 Q3 | 100.27 Thousand USD | -7.69% |
| 2011 Q2 | 108.63 Thousand USD | 121.43% |
| 2010 FY | 53.83 Thousand USD | -13.7% |
| 2010 Q2 | 63.13 Thousand USD | -7.75% |
| 2010 Q3 | 58.52 Thousand USD | -7.29% |
| 2010 Q1 | 68.43 Thousand USD | 9.7% |
| 2010 Q4 | 53.83 Thousand USD | -8.01% |
| 2009 Q2 | 79.23 Thousand USD | 0.0% |
| 2009 FY | 62.38 Thousand USD | 0.0% |
| 2009 Q4 | 62.38 Thousand USD | -7.04% |
| 2009 Q3 | 67.1 Thousand USD | -15.31% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | 110.45 Thousand USD | 0.0% |
| 2007 Q4 | - USD | -100.0% |
| 2007 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Achiko AG | 2.12 Million USD | 90.854% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 2.65 Million USD | 92.7% |
| Cannabis Sativa, Inc. | - USD | -Infinity% |
| CompuMed, Inc. | - USD | -Infinity% |
| CompuGroup Medical SE & Co. KGaA | 777.31 Million USD | 99.975% |
| Cogstate Limited | 454.9 Thousand USD | 57.346% |
| CareView Communications, Inc. | 139.09 Thousand USD | -39.494% |
| Craneware plc | 27.37 Million USD | 99.291% |
| Caduceus Software Systems Corp. | 2.41 Million USD | 91.95% |
| Certive Solutions Inc. | 1.16 Million USD | 83.384% |
| Drug Free Solution, Inc. | - USD | -Infinity% |
| DATATRAK International, Inc. | - USD | -Infinity% |
| Strainsforpains, Inc. | 1.93 Million USD | 89.962% |
| Healixa Inc. | - USD | -Infinity% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | - USD | -Infinity% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | - USD | -Infinity% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | - USD | -Infinity% |
| IQ-AI Limited | - USD | -Infinity% |
| Cannabiz Mobile, Inc. | 494.05 Thousand USD | 60.726% |
| Mednow Inc. | 280.58 Thousand USD | 30.846% |
| Galileo Life Sciences, Inc. | - USD | -Infinity% |
| MediXall Group, Inc. | 189.45 Thousand USD | -2.416% |
| Mitesco, Inc. | - USD | -Infinity% |
| MobileSmith, Inc. | 282.53 Thousand USD | 31.323% |
| NantHealth, Inc. | 264.73 Million USD | 99.927% |
| Net Medical Xpress Solutions, Inc. | 650 Thousand USD | 70.148% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | - USD | -Infinity% |
| Patient Access Solutions, Inc. | 200 Thousand USD | 2.983% |
| PPJ Healthcare Enterprises, Inc. | - USD | -Infinity% |
| Medical Cannabis Payment Solutions, Inc. | - USD | -Infinity% |
| Renalytix Plc | 4.33 Million USD | 95.52% |
| Revium Recovery Inc. | - USD | -Infinity% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | - USD | -Infinity% |
| Vaso Corporation | 6000.00 USD | -3133.917% |
| Vynleads, Inc. | - USD | -Infinity% |